2nd LNP Immunogenicity and Toxicity Summit Boston Park Plaza, Boston
The 2nd LNP Immunogenicity and Toxicity Summit is set to unite 100+ PKPD, Immunology, Safety, Toxicology experts from biopharma and academia. This is your opportunity to join key opinion leaders within the industry to explore the steep progress being made in the space and actively address the field’s most pressing challenges through multiple deep-dive discussions.
In collaboration with Pfizer, BioNTech, Sanofi and Eli Lilly, this 3-day summit will bring together senior leaders dedicated to understanding and predicting the next wave of LNP’s immunogenicity and toxicity challenges, to support drug developers to ensure smooth filing with long-term patient safety in mind.
This year we are moving alongside the pharmaceutical industry and bringing the focus to accurately measuring immuno-tox of their LNP for regulatory IND filing, using different payloads in LNPs beyond mRNA and understanding the importance of accurate immunogenicity and toxicity studies for approval and patient safety.